达拉图姆单一治疗耐火性狼性炎的治疗方法
Dario Roccatello1, Roberta Fenoglio2, Ilaria Caniggia2
1University Center of Excellence on Nephrological, Rheumatological and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) including Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), San Giovanni Bosco Hub Hospital, ASL Città di Torino and Department of Clinical and Biological Sciences of the University of Turin, Turin, Italy. dario.roccatello@unito.it.
达拉图马布是一种抗CD38抗体,在治疗难治性狼性炎 (LN) 中表现有前途. 在6名患者中,有5名患者经历了12个月后疾病活性降低,蛋白尿和功能改善.
科学领域:
- 免疫学 免疫学 免疫学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 类风湿病学 类风湿病学
背景情况:
- 抗治疗性狼性炎 (LN) 具有严重的不良结果风险,并可能危及生命.
- 目前对耐火性LN的治疗选择有限,需要探索新的治疗策略.
更多相关视频
09:43Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
